|
시장보고서
상품코드
1986713
자기 비즈 시장 규모, 점유율, 동향 분석 : 용도별, 지역별, 부문별 예측(2026-2033년)Magnetic Beads Market Size, Share & Trends Analysis Report By Application (Bioresearch, In-vitro Diagnostics), By Region (North America, Europe, Asia Pacific, CSA, MEA), And Segment Forecasts, 2026 - 2033 |
||||||
자기 비즈 시장 요약
세계의 자기 비즈 시장 규모는 2025년에 51억 9,000만 달러로 추계되며, 2033년까지 90억 7,000만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 5.1%로 성장할 전망입니다.
이 시장은 사용 편의성, 최소한의 처리 요구 사항 및 신뢰성으로 인해 분자 생물학 분야에서의 응용 분야에서 빠르게 성장하고 있습니다.
또한 게놈 플라스미드, DNA, RNA, 단백질, 미토콘드리아 DNA 등 다양한 생체 분자의 정제에 사용되고 있으며, 이는 시장 성장을 촉진할 것으로 예상됩니다. 의료 제품의 수요 증가에 힘입어 마그네틱 비드 시장은 크게 성장할 것으로 예상됩니다. 예를 들어 조작의 용이성, 빠른 결과, 그리고 DTC 방식(Direct-to-Consumer)의 검사는 체외진단약의 보급을 더욱 촉진하고 있습니다. 또한 검사실 밖이나 가정에서의 POC(Point of Care) 검사 증가 추세와 더불어 인구 증가와 만성질환의 확산이 결합되어 마그네틱 비드의 사용을 촉진할 것으로 예상됩니다.
자주 묻는 질문
목차
제1장 분석 방법·범위
제2장 개요
제3장 자기 비즈 시장 : 변동 요인·동향·범위
제4장 자기 비즈 시장 : 용도별 전망·추정·예측
제5장 자기 비즈 시장 : 지역별 전망·추정·예측
제6장 경쟁 구도
KSA 26.04.29Magnetic Beads Market Summary
The global magnetic beads market size was estimated at USD 5.19 billion in 2025 and is projected to reach USD 9.07 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. The market is witnessing rapid growth in molecular biology applications owing to their ease of use, minimal processing requirements, and reliability.
It is further used to purify various biomolecules such as genomic plasmids, DNA, RNA, proteins, and mitochondrial DNA, which is expected to drive the market. The market for magnetic beads is expected to grow significantly, driven by increasing demand for healthcare products. For instance, ease of operations, rapid results, and direct-to-consumer testing further facilitate the adoption of in-vitro diagnostics. Moreover, the growing trend of point-of-care (POC) testing outside the laboratory or at the doorstep, coupled with the increasing population and the widespread spread of chronic diseases, is expected to promote the use of magnetic beads.
Global Magnetic Beads Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the magnetic beads market report based on application, and region:
- Application Outlook (Volume, Kg; Revenue, USD Million; 2021 - 2033)
- Bioresearch
- In-vitro Diagnostics
- Others
- Regional Outlook (Volume, Kg; Revenue, USD Million; 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Asia Pacific
- China
- India
- Japan
- Central & South America
- Brazil
- Middle East & Africa
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Types & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Type & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Insights
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. Magnetic Beads Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.4. Technology Overview
- 3.5. Regulatory Framework
- 3.6. Market Dynamics
- 3.6.1. Market Driver Analysis
- 3.6.2. Market Restraint Analysis
- 3.6.3. Industry Challenges
- 3.7. Porter's Five Forces Analysis
- 3.7.1. Supplier Power
- 3.7.2. Buyer Power
- 3.7.3. Substitution Threat
- 3.7.4. Threat from New Entrants
- 3.7.5. Competitive Rivalry
- 3.8. PESTEL Analysis
- 3.8.1. Political Landscape
- 3.8.2. Economic Landscape
- 3.8.3. Social Landscape
- 3.8.4. Technological Landscape
- 3.8.5. Environmental Landscape
- 3.8.6. Legal Landscape
Chapter 4. Magnetic Beads Market: Application Outlook Estimates & Forecasts
- 4.1. Magnetic Beads Market: Application Movement Analysis, 2025 & 2033
- 4.1.1. Bioresearch
- 4.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 4.1.2. In-vitro Diagnostics
- 4.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 4.1.3. Others
- 4.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 4.1.1. Bioresearch
Chapter 5. Magnetic Beads Market Regional Outlook Estimates & Forecasts
- 5.1. Regional Snapshot
- 5.2. Magnetic Beads Market: Regional Movement Analysis, 2025 & 2033
- 5.3. North America
- 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.3.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.3.3. U.S.
- 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.3.3.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.3.4. Canada
- 5.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.3.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.3.5. Mexico
- 5.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.3.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.4. Europe
- 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.4.3. Germany
- 5.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.4.3.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.4.4. UK
- 5.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.4.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.4.5. France
- 5.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.4.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.5. Asia Pacific
- 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.5.3. China
- 5.5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.5.3.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.5.4. India
- 5.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.5.4.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.5.5. Japan
- 5.5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.5.5.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.6. Central & South America
- 5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.6.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.6.3. Brazil
- 5.6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.6.3.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
- 5.7. Middle East & Africa
- 5.7.1. Market estimates and forecast, 2021 - 2033 (USD Million) (Kg)
- 5.7.2. Market estimates and forecast, by application, 2021 - 2033 (USD Million) (Kg)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Vendor Landscape
- 6.3. Company Market Share Analysis & Market Positioning
- 6.4. Strategy Mapping
- 6.5. Heat Map Analysis
- 6.6. Company Profiles/Listing
- 6.6.1. Thermo Fisher Scientific Inc.
- 6.6.1.1. Participant's overview
- 6.6.1.2. Financial performance
- 6.6.1.3. Product benchmarking
- 6.6.2. Merck KGaA
- 6.6.2.1. Participant's overview
- 6.6.2.2. Financial performance
- 6.6.2.3. Product benchmarking
- 6.6.3. Bangs Laboratories Inc.
- 6.6.3.1. Participant's overview
- 6.6.3.2. Financial performance
- 6.6.3.3. Product benchmarking
- 6.6.4. Spherotech, Inc
- 6.6.4.1. Participant's overview
- 6.6.4.2. Financial performance
- 6.6.4.3. Product benchmarking
- 6.6.5. GenScript
- 6.6.5.1. Participant's overview
- 6.6.5.2. Financial performance
- 6.6.5.3. Product benchmarking
- 6.6.6. CardioGenics Inc.
- 6.6.6.1. Participant's overview
- 6.6.6.2. Financial performance
- 6.6.6.3. Product benchmarking
- 6.6.7. Bio-Rad Laboratories, Inc
- 6.6.7.1. Participant's overview
- 6.6.7.2. Financial performance
- 6.6.7.3. Product benchmarking
- 6.6.8. Miltenyi Biotec
- 6.6.8.1. Participant's overview
- 6.6.8.2. Financial performance
- 6.6.8.3. Product benchmarking
- 6.6.9. Ferrotec (USA) Corporation
- 6.6.9.1. Participant's overview
- 6.6.9.2. Financial performance
- 6.6.9.3. Product benchmarking
- 6.6.10. Eurofins Technologies
- 6.6.10.1. Participant's overview
- 6.6.10.2. Financial performance
- 6.6.10.3. Product benchmarking
- 6.6.11. Micromod Partikeltechnologie GmbH
- 6.6.11.1. Participant's overview
- 6.6.11.2. Financial performance
- 6.6.11.3. Product benchmarking
- 6.6.12. New England Biolabs
- 6.6.12.1. Participant's overview
- 6.6.12.2. Financial performance
- 6.6.12.3. Product benchmarking
- 6.6.13. Rockland Immunochemicals, Inc.
- 6.6.13.1. Participant's overview
- 6.6.13.2. Financial performance
- 6.6.13.3. Product benchmarking
- 6.6.1. Thermo Fisher Scientific Inc.
